SPL Intent-Use categories for Treatment Modality #184
Description
FDA's SPL contains information on the intended use of products that corresponds nicely to Treament Modality in Inxight.
https://www.fda.gov/industry/structured-product-labeling-resources/intent-use
I forget how this information comes from FRDB - but one might be able to supplement it with FDA SPL data.
Primary
Substance halts or slows disease progression. Treatment often targets the primary pathology of a disease.
Preventing
Substance is intended to prevent the development of a medical condition.
Palliative
Substance improves the quality of life by alleviating the associated symptoms, without necessarily affecting the underlying pathology.
Secondary
Substance treats adverse effects associated with the treatment of a condition.
Diagnostic
A substance used for diagnostic purposes, including disease detection and monitoring of disease progression.
Inactive Ingredient
An ingredient of a given formulation (most frequently, an excipient) that does not exhibit pharmacological activity. In this case, a condition is only related to such compound via the formulation used to affect (treat or diagnose) this condition.